Drug shortage
Dopamine Hydrochloride Injection · Baxter Healthcare
FDA drug shortage · Current · updated Apr 7, 2025
Key facts
| Generic name | Dopamine Hydrochloride Injection |
|---|---|
| Proprietary name | Dopamine Hydrochloride In Dextrose 5% In Plastic Container |
| Company | Baxter Healthcare |
| Presentation | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) |
| Dosage form | Injection |
| Strength | 80 mg/100 mL |
| Status | Current |
| Therapeutic category | Cardiovascular |
| Package NDCs | 0338-1005-02 |
| First posted | Nov 6, 2017 |
| Last updated | Apr 7, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: